We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 833 results
  1. Statine nach Nierentransplantation

    Lutz Renders in Die Nephrologie
    Article 16 August 2023
  2. Lercanidipine

    Article 20 August 2022
  3. Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

    Background

    Cardiovascular disease is the leading cause of mortality in Germany. Cardiovascular risk can be mitigated with long-term lipid-lowering...

    Wolfgang Koenig, Elke S. Lorenz, ... Ioanna Gouni-Berthold in Clinical Research in Cardiology
    Article Open access 21 August 2023
  4. Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)

    Purpose of Review

    The purpose of this review is to critically discuss whether more aggressive lipid-lowering strategies are needed in patients with...

    Natalie Arnold, Wolfgang Koenig in Current Atherosclerosis Reports
    Article Open access 28 November 2023
  5. Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies—Analysis of the WHO Pharmacovigilance Database

    Purpose

    While statins and antiplatelet therapies are largely prescribed together worldwide, limited information is available on the safety of their...

    Vincent Roule, Joachim Alexandre, ... Charles Dolladille in Cardiovascular Drugs and Therapy
    Article 28 April 2023
  6. Heart transplantation and human immunodeficiency virus–navigating drug-drug interactions: a case report

    Background

    Antiretroviral therapy (ART) has led to a decline in human immunodeficiency virus (HIV)-related mortality, but comorbidities, including...

    Thamer A. Almangour, Preston T. Skersick, ... Claire E. Farel in AIDS Research and Therapy
    Article Open access 11 August 2023
  7. Bempedoic Acid: for Whom and When

    Purpose of Review

    The aim of creating an orally active non-statin cholesterol-lowering drug was achieved with bempedoic acid, a small linear molecule...

    Massimiliano Ruscica, Cesare R. Sirtori, ... Alberto Corsini in Current Atherosclerosis Reports
    Article Open access 28 July 2022
  8. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus

    Diabetic dyslipidemia is characterised by low HDL-C and high triglyceride levels. Unlike the Caucasian population, though LDL-C levels are not very...

    Banshi Saboo, Sanjay Agarwal, ... Bipin Sethi in International Journal of Diabetes in Develo** Countries
    Article 01 January 2022
  9. Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique

    Background and objective

    Rhabdomyolysis (RM) is a life-threatening adverse drug reaction in which statins are the one commonly related to RM. The...

    Patratorn Kunakorntham, Oraluck Pattanaprateep, ... Ammarin Thakkinstian in BMC Medical Informatics and Decision Making
    Article Open access 05 September 2022
  10. Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data

    Abstract Background

    Bariatric surgery has been shown to improve hyperlipidemia, decreasing the need for statin medications. Although maintaining...

    Abdulrahman A Alsuhibani, Omar A Al-Obeed, ... Ana L. Hincapie in Obesity Surgery
    Article Open access 22 February 2024
  11. Association between triglyceride glucose index and all-cause mortality in patients with cerebrovascular disease: a retrospective study

    Background

    Triglyceride glucose (TyG) is associated with stroke, atherosclerosis, and adverse clinical outcomes. However, its correlation with...

    Yong’An Jiang, Peng Chen, ... Yan Zhang in Diabetology & Metabolic Syndrome
    Article Open access 03 January 2024
  12. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    Introduction

    The cognitive safety of monoclonal antibody proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) has been established in...

    Jose Seijas-Amigo, Mª José Mauriz-Montero, ... María Jesús García-Verde in American Journal of Cardiovascular Drugs
    Article Open access 23 August 2023
  13. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study

    Background

    We evaluated the effect of statin use on new-onset type 2 diabetes among individuals without atherosclerotic cardiovascular disease (ASCVD)...

    Eonji Na, Sunyoung Cho, ... Euna Han in Cardiovascular Diabetology
    Article Open access 16 May 2020
  14. Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China

    Background

    Lipid management with a low-density lipoprotein cholesterol (LDL-C) goal of < 1.4 mmol/L is recommended for patients with acute coronary...

    Tongshuai Guo, Chao Chu, ... Jianjun Mu in BMC Cardiovascular Disorders
    Article Open access 01 July 2023
  15. Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature

    Background

    Gliomas represent most common primary brain tumors. Glioblastoma (GBM) is the most common subtype and carries a poor prognosis. There is...

    Luis F. Rendon, Ishaan A. Tewarie, ... Rania A. Mekary in Drugs
    Article 05 February 2022
  16. With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?

    Purpose of Review

    Statins inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase in the liver and reduce atherosclerotic cardiovascular...

    Anurag Mehta, Dave L. Dixon, ... Salim S. Virani in Current Cardiology Reports
    Article 27 March 2023
Did you find what you were looking for? Share feedback.